Elevated Calcium after Acute Ischemic Stroke: Association with a Poor Short-Term Outcome and Long-Term Mortality
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background and Purpose An elevated intracellular calcium level is known to be a major initiator and activator of ischemic cell death pathway; however, in recent studies, elevated serum calcium levels have been associated with better clinical outcomes and smaller cerebral infarct volumes. The pathophysiological role played by calcium in ischemic stroke is largely unknown. Methods Acute stroke patients from a prospective stroke registry, consecutively admitted during October 2002-September 2008, were included. Significant associations between the modified Rankin scale distribution at discharge and serum calcium or albumin-corrected calcium were identified using ordinal logistic regression analysis. Cox proportional hazard models were used for survival analysis. Results Mean serum calcium and albumin-corrected calcium levels of the 1,915 participants on admission were 8.97±0.58 mg/dL and 9.07±0.49 mg/dL, respectively. Second [adjusted odds ratio 1.32 (95% confidence interval 1.07-1.61)] and third [1.24 (1.01-1.53)] tertiles of serum calcium level and the third [1.24 (1.01-1.53)] tertile of albumin-corrected calcium level were found to be independent risk factors for a poor discharge outcome. Significant relationships were observed with serum calcium [1.19 (1.03-1.38)] and albumin-corrected calcium [1.21(1.01-1.44)] as linear variables. However, only albumin-corrected calcium was associated with long-term mortality, third tertile [adjusted hazard ratio 1.40 (1.07-1.83)], and increase by 1 mg/dL [1.46 (1.16-1.84)]. Conclusions Elevated albumin-corrected serum calcium levels are associated with a poorer short-term outcome and greater risk of long-term mortality after acute ischemic stroke.
Abstract
Background and Purpose An elevated intracellular calcium level is known to be a major initiator and activator of ischemic cell death pathway; however, in recent studies, elevated serum calcium levels have been associated with better clinical outcomes and smaller cerebral infarct volumes. The pathophysiological role played by calcium in ischemic stroke is largely unknown. Methods Acute stroke patients from a prospective stroke registry, consecutively admitted during October 2002-September 2008, were included. Significant associations between the modified Rankin scale distribution at discharge and serum calcium or albumin-corrected calcium were identified using ordinal logistic regression analysis. Cox proportional hazard models were used for survival analysis. Results Mean serum calcium and albumin-corrected calcium levels of the 1,915 participants on admission were 8.97±0.58 mg/dL and 9.07±0.49 mg/dL, respectively. Second [adjusted odds ratio 1.32 (95% confidence interval 1.07-1.61)] and third [1.24 (1.01-1.53)] tertiles of serum calcium level and the third [1.24 (1.01-1.53)] tertile of albumin-corrected calcium level were found to be independent risk factors for a poor discharge outcome. Significant relationships were observed with serum calcium [1.19 (1.03-1.38)] and albumin-corrected calcium [1.21(1.01-1.44)] as linear variables. However, only albumin-corrected calcium was associated with long-term mortality, third tertile [adjusted hazard ratio 1.40 (1.07-1.83)], and increase by 1 mg/dL [1.46 (1.16-1.84)]. Conclusions Elevated albumin-corrected serum calcium levels are associated with a poorer short-term outcome and greater risk of long-term mortality after acute ischemic stroke.
참고문헌 (29)
- Kristian T, "Calcium in ischemic cell death", Stroke, 29, pp.705~718 (1998)
- Nicholson C, "Calcium modulation in brain extracellular microenvironment demonstrated with ion-selective micropipette", Proc Natl Acad Sci U S A, 74, pp.1287~1290 (1977)
- Tymianski M, "Normal and abnormal calcium homeostasis in neurons: a basis for the pathophysiology of traumatic and ischemic central nervous system injury", Neurosurgery, 38, pp.1176~1195 (1996)
- Gelmers HJ, "A controlled trial of nimodipine in acute ischemic stroke", N Engl J Med, 318, pp.203~207 (1988)
- Mohr JP, "Meta-analysis of oral nimodipine trials in acute ischemic stroke", Cerebrovasc Dis, 4, pp.194~196 (1994)
- Walker GL, "Hypercalcaemia associated with cerebral vasospasm causing infarction", J Neurol Neurosurg Psychiatry, 43, pp.464~467 (1980)
- Bogousslavsky J, "Uncommon causes of stroke" (2001), Cambridge University Press
- Ovbiagele B, "Are elevated admission calcium levels associated with better outcomes after ischemic stroke?", Neurology, 67, pp.170~173 (2006)
- Buck BH, "Association of higher serum calcium levels with smaller infarct volumes in acute ischemic stroke", Arch Neurol, 64, pp.1287~1291 (2007)
- Appel SA, "Serum calcium levels and long-term mortality in patients with acute stroke", Cerebrovasc Dis, 31, pp.93~99 (2011)
- Adams HP Jr, "Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment", Stroke, 24, pp.35~41 (1993)
- Chobanian AV, "Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure", Hypertension, 42, pp.1206~1252 (2003)
- Kim BJ, "Low level of low-density lipoprotein cholesterol increases hemorrhagic transformation in large artery atherothrombosis but not in cardioembolism", Stroke, 40, pp.1627~1632 (2009)
- Alberti KG, "Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation", Diabet Med, 15, pp.539~553 (1998)
- Bushinsky DA, "Electrolyte quintet: Calcium", Lancet, 352, pp.306~311 (1998)
- Jee SH, "Body-mass index and mortality in Korean men and women", N Engl J Med, 355, pp.779~787 (2006)
- Ryu WS, "Effects of low serum triglyceride on stroke mortality: a prospective follow-up study", Atherosclerosis, 212, pp.299~304 (2010)
- Payne RB, "Interpretation of serum total calcium: effects of adjustment for albumin concentration on frequency of abnormal values and on detection of change in the individual", J Clin Pathol, 32, pp.56~60 (1979)
- Michaels RL, "Glutamate neurotoxicity in vitro: antagonist pharmacology and intracellular calcium concentrations", J Neurosci, 10, pp.283~292 (1990)
- Milani D, "Excitatory amino acid-induced alterations of cytoplasmic free Ca2+ in individual cerebellar granule neurons: role in neurotoxicity", J Neurosci Res, 28, pp.434~441 (1991)
- Marcaida G, "Lack of correlation between glutamate-induced depletion of ATP and neuronal death in primary cultures of cerebellum", Brain Res, 695, pp.146~150 (1995)
- Marcaida G, "Glutamate induces a calcineurin-mediated dephosphorylation of Na+,K(+)-ATPase that results in its activation in cerebellar neurons in culture", J Neurochem, 66, pp.99~104 (1996)
- Dawson VL, "Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures", J Neurosci, 13, pp.2651~2661 (1993)
- Nicholls DG, "A role for the mitochondrion in the protection of cells against calcium overload?", Prog Brain Res, 63, pp.97~106 (1985)
- Gunter TE, "Mechanisms by which mitochondria transport calcium", Am J Physiol, 258, pp.C755~786 (1990)
- Gunter TE, "Mitochondrial calcium transport: physiological and pathological relevance", Am J Physiol, 267, pp.C313~339 (1994)
- Zoratti M, "The mitochondrial permeability transition", Biochim Biophys Acta, 1241, pp.139~176 (1995)
- Ovbiagele B, "Serum calcium as prognosticator in ischemic stroke", Stroke, 39, pp.2231~2236 (2008)
- Valero-Politi J, "Annual rhythmic and non-rhythmic biological variation of magnesium and ionized calcium concentrations", Clin Chem Lab Med, 39, pp.45~49 (2001)